Why Inovio Pharmaceuticals Inc. Is Sinking Today
In response to the company reporting disappointing third-quarter results, shares of Inovio Pharmaceuticals (NASDAQ: INO), a clinical-stage biotech focused on vaccines, fell 14% as of 2:15 p.m. EST on Thursday.
Here's a review of the headline numbers from the quarter:
Looking beyond the financials, here's a quick overview of some of the company's recent clinical news:
Source: Fool.com
Inovio Pharma Stock
€0.53
-2.240%
Currently there is a rather negative sentiment for Inovio Pharma with 2 Buy predictions and 4 Sell predictions..
However, we have a potential of 1967.67% for Inovio Pharma as the target price of 11 € is above the current price of 0.53 €.
